Jeffrey Bloss
Chief Tech/Sci/R&D Officer chez NUCANA PLC
Fortune : 26 $ au 31/03/2024
Profil
Jeffrey D.
Bloss is currently the Director at National Pharmaceutical Council, Senior Vice President-Medical & Scientific Affairs at Astellas US LLC, and Chief Medical Officer at NuCana Plc.
He previously worked as Group Medical Director at Genentech, Inc., Oncology Director at Eli Lilly & Co., Director-Clinical Research & Compliance Office at the University of Missouri, Vice President-Clinical Development at Onyx Pharmaceuticals, Inc., Chief Medical Officer at Xencor, Inc., and Principal at United States Air Force Medical Corp.
He was also the Chief Medical Officer at Tarveda Therapeutics, Inc. from 2018 to 2021 and the Chief Medical Officer & Senior VP-Medical Affairs at Aegerion Pharmaceuticals Ltd.
(United Kingdom) from 2017 to 2018.
Bloss holds a doctorate from Thomas Jefferson University and an undergraduate degree from Juniata College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUCANA PLC
0,00% | 31/12/2023 | 100 ( 0,00% ) | 26 $ | 31/03/2024 |
Postes actifs de Jeffrey Bloss
| Sociétés | Poste | Début |
|---|---|---|
| NUCANA PLC | Chief Tech/Sci/R&D Officer | 10/08/2021 |
Astellas US LLC
 Astellas US LLC Pharmaceuticals: MajorHealth Technology Part of Astellas Pharma, Inc., Astellas US LLC is a private company that manufactures and markets pharmaceutical products. The company is based in Northbrook, IL. The CEO of the company is Kenji Yasukawa. | Chief Tech/Sci/R&D Officer | 01/10/2012 |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Director/Board Member | 04/11/2016 |
Anciens postes connus de Jeffrey Bloss
| Sociétés | Poste | Fin |
|---|---|---|
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Chief Tech/Sci/R&D Officer | 01/08/2021 |
Aegerion Pharmaceuticals Ltd. (United Kingdom)
 Aegerion Pharmaceuticals Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Aegerion Pharmaceuticals Ltd. is a British UK-based company founded in 2012. The private company manufactures pharmaceutical products. | Chief Tech/Sci/R&D Officer | 01/08/2018 |
| United States Air Force Medical Corp. | Corporate Officer/Principal | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | - |
| University of Missouri | Corporate Officer/Principal | - |
Formation de Jeffrey Bloss
| Thomas Jefferson University | Doctorate Degree |
| Juniata College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| XENCOR, INC. | Health Technology |
| NUCANA PLC | Health Technology |
| Entreprise privées | 7 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
National Pharmaceutical Council
National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Commercial Services |
Astellas US LLC
Astellas US LLC Pharmaceuticals: MajorHealth Technology Part of Astellas Pharma, Inc., Astellas US LLC is a private company that manufactures and markets pharmaceutical products. The company is based in Northbrook, IL. The CEO of the company is Kenji Yasukawa. | Health Technology |
| United States Air Force Medical Corp. | |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Health Technology |
Aegerion Pharmaceuticals Ltd. (United Kingdom)
Aegerion Pharmaceuticals Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Aegerion Pharmaceuticals Ltd. is a British UK-based company founded in 2012. The private company manufactures pharmaceutical products. | Health Technology |
